Drug Shortage Report for BRIMONIDINE P

Last updated on 2021-11-01 History
Report ID 75644
Drug Identification Number 02301334
Brand name BRIMONIDINE P
Common or Proper name Brimonidine P
Company Name AA PHARMA INC
Market Status MARKETED
Active Ingredient(s) BRIMONIDINE TARTRATE
Strength(s) 0.15%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 10ML
ATC code S01EA
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-05-15
Actual start date
Estimated end date 2021-09-16
Actual end date 2021-10-20
Shortage status Resolved
Updated date 2021-11-01
Company comments
Health Canada comments
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2021-11-01 French Compare
v14 2021-11-01 English Compare
v13 2021-06-17 French Compare
v12 2021-06-17 English Compare
v11 2020-07-23 French Compare
v10 2020-07-23 English Compare
v9 2020-04-06 French Compare
v8 2020-04-06 English Compare
v7 2020-01-30 French Compare
v6 2020-01-30 English Compare
v5 2020-01-13 French Compare
v4 2020-01-13 English Compare
v3 2019-05-16 English Compare
v2 2019-02-13 French Compare
v1 2019-02-13 English Compare